Non-insulin-dependent diabetes mellitus. Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group: 15 grams of powdered fenugreek seeds in doses of 5 grams three times a day between meals, dissolved in water, besides routine diabetic drugs, for 8 weeks. Intervent
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: type 2 diabetes 30-65 years old up to 10 year diabetic history Body Mass Index<35
Exclusion criteria
Exclusion criteria: insulin therapy menopause or hysterectomy (women) having any certain diseases or using any certain medications other than diabetic ones having allergy to Fabaceae family herbs using dietary supplements and other medicinal plants for at least three months prior to the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hip circumference. Timepoint: baseline and 8 weeks after intervention. Method of measurement: measuring tape.;Waist circumference. Timepoint: baseline and 8 weeks after intervention. Method of measurement: measuring tape.;Blood pressure. Timepoint: baseline and 8 weeks after intervention. Method of measurement: sphygmomanometer.;Alanine Amino Transferase. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;Aspartate aminotransferase. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;Alkaline phosphatase. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;Depression and anxiety. Timepoint: baseline and 8 weeks after intervention. Method of measurement: "Hospital Anxiety and Depression Scale" questionnaire.;Irisin. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;Triglyceride. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;Low-density lipoprotein. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;High-density lipoprotein. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;Fasting plasma glucose. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;2-h post prandial glucose. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;Insulin. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;HbA1C. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;Blood urea nitrogen. Timepoint: baseline and 8 weeks after intervention. Meth | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRahele Tavakoly
Kerman University of Medical Sciences
Outcome results
None listed